Catalyst
Slingshot members are tracking this event:
CollPlant Receives CE Mark for VergenixFG Wound Filler
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLPT.TA | Community voting in process | |||||
Additional Information
Yehiel Tal, Chief Executive Officer of CollPlant, stated, "We are delighted to have received the CE Mark that will enable to market Vergenix™FG in Europe. Vergenix™ FG is one of the world's first medical devices containing a recombinant collagen sourced from plants. We are now seeking distributors in Europe in order to set up the necessary sales infrastructure, where initial sales are expected to begin in 2016."
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ce Mark, Vergenixfg, Wound Filler, Rhcollagen
